Cite
Studies from Sichuan University in the Area of Rheumatoid Arthritis Described (Dexamethasone Palmitate Encapsulated In Palmitic Acid Modified Human Serum Albumin Nanoparticles for the Treatment of Rheumatoid Arthritis)
MLA
“Studies from Sichuan University in the Area of Rheumatoid Arthritis Described (Dexamethasone Palmitate Encapsulated In Palmitic Acid Modified Human Serum Albumin Nanoparticles for the Treatment of Rheumatoid Arthritis).” Health & Medicine Week, 11 Oct. 2024, p. 7463. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.811273274&authtype=sso&custid=ns315887.
APA
Studies from Sichuan University in the Area of Rheumatoid Arthritis Described (Dexamethasone Palmitate Encapsulated In Palmitic Acid Modified Human Serum Albumin Nanoparticles for the Treatment of Rheumatoid Arthritis). (2024, October 11). Health & Medicine Week, 7463.
Chicago
Health & Medicine Week. 2024. “Studies from Sichuan University in the Area of Rheumatoid Arthritis Described (Dexamethasone Palmitate Encapsulated In Palmitic Acid Modified Human Serum Albumin Nanoparticles for the Treatment of Rheumatoid Arthritis),” October 11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.811273274&authtype=sso&custid=ns315887.